90,500 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Prospector Partners LLC

Prospector Partners LLC acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 90,500 shares of the company’s stock, valued at approximately $2,100,000. Prospector Partners LLC owned about 0.05% of Option Care Health as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in OPCH. Graypoint LLC purchased a new position in Option Care Health in the fourth quarter valued at approximately $1,161,000. Charles Schwab Investment Management Inc. raised its stake in shares of Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock valued at $58,235,000 after buying an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. lifted its position in shares of Option Care Health by 38.1% during the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock valued at $1,596,000 after buying an additional 18,992 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in Option Care Health in the 4th quarter worth about $327,000. Finally, Barclays PLC increased its holdings in Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after acquiring an additional 199,454 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on OPCH. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research lifted their price target on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. JPMorgan Chase & Co. increased their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $33.00.

Option Care Health Price Performance

OPCH stock opened at $33.54 on Friday. The firm has a 50 day simple moving average of $32.97 and a two-hundred day simple moving average of $28.51. The stock has a market cap of $5.51 billion, a PE ratio of 28.18, a P/E/G ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.